Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

van der Heijde, Desiree   •   Kivitz, Alan   •   Schiff, Michael H   •   Sieper, Joachim   •   Dijkmans, Ben A C   •   Braun, Jurgen   •   Dougados, Maxime   •   Reveille, John D   •   Wong, Robert L   •   Kupper, Hartmut   •   Davis, John C Jr

published in: Arthritis and rheumatism



endpoint

Adalimumab has (optional: compared with placebo) proved to be better.
general condition better


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection therapy
conservative therapy → injection

publication details

10.1002/art.21913
pubmed
16802350
2006
Journal Article
randomized controlled trial
yes
prospective
1+